HEATHER SHEWMAKE: Open Payments
NPI 1184947798 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 13 payments from 7 companies in 2025. Trend: 2023 $1,410 · 2024 $803 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $130 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 2 | $76 |
| ABIOMED | 2 | $71 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, LEQVIO, CAMZYOS, LifeVest, LIVTENCITY, JARDIANCE.
Industry payments across TX — which companies pay providers there.
